tiprankstipranks
pc:brave

Braveheart Bio

Therapeutics
Braveheart Bio is a late clinical-stage biotechnology company developing novel therapeutics for hypertrophic cardiomyopathy and related conditions. The company is backed by experienced life science investors and is advancing BHB-1893 through late-stage clinical development with the goal of establishing a new standard of care.

Leadership & Board

Currently, no data available

Latest Estimated Valuation

Estimated Valuation―
Estimated Valuation―
Total Amount Raised$185M
Total Amount Raised$185M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$185M
Latest Funding Amount$185M
Latest Funding RoundSeries A
Latest Funding RoundSeries A
Post-Money Valuation―
Post-Money Valuation―

Funding Round

Funding Date
Funding Round
Amount Raised
Post-Money Valuation
Nov 05, 2025
Series A
$185.00M
―

Investors

Investor Name
Funding Round
OrbiMed
Series A
Forbion
Series A
Andreessen Horowitz (a16z)
Series A
Frazier Life Sciences
Series A
Enavate Sciences
Series A

Related News and Analysis

Braveheart Bio Readies Global Pivotal Trial After Strong Phase 2 Data for HCM Drug BHB-1893

Braveheart Bio Readies Global Pivotal Trial After Strong Phase 2 Data for HCM Drug BHB-1893

New updates have been reported about Braveheart Bio. Braveheart Bio is advancing its lead cardiac myosin inhibitor, BHB-1893,...
11d ago
BRAVE
Braveheart Bio Strengthens Clinical Leadership as It Prepares Global Pivotal oHCM Trial

Braveheart Bio Strengthens Clinical Leadership as It Prepares Global Pivotal oHCM Trial

New updates have been reported about Braveheart Bio. Braveheart Bio has appointed Emil deGoma, M.D., as Chief Medical...
15d ago
BRAVE
Braveheart Bio Targets Investor Visibility With TD Cowen Conference Meetings

Braveheart Bio Targets Investor Visibility With TD Cowen Conference Meetings

New updates have been reported about Braveheart Bio. Braveheart Bio will seek to deepen institutional investor engagement as...
2M ago
BRAVE
Braveheart Bio Strengthens Leadership Bench Ahead of 2026 Global Phase 3 oHCM Trial

Braveheart Bio Strengthens Leadership Bench Ahead of 2026 Global Phase 3 oHCM Trial

New updates have been reported about Braveheart Bio. Braveheart Bio has expanded its senior leadership team as it...
2M ago
BRAVE
Braveheart Bio to Highlight Late-Stage Cardiomyopathy Program at J.P. Morgan Healthcare Conference

Braveheart Bio to Highlight Late-Stage Cardiomyopathy Program at J.P. Morgan Healthcare Conference

New updates have been reported about Braveheart Bio. Braveheart Bio will use its participation in the 44th Annual...
3M ago
BRAVE
Braveheart Bio Secures $185M Series A to Advance HCM Therapeutic

Braveheart Bio Secures $185M Series A to Advance HCM Therapeutic

New updates have been reported about Braveheart Bio (PC:BRAVE) Braveheart Bio, a biotechnology company specializing in treatments for...
5M ago
BRAVE
Edge Delta Drops Telemetry Pipeline Fees to Drive AI Teammates Adoption

Edge Delta Drops Telemetry Pipeline Fees to Drive AI Teammates Adoption

New updates have been reported about Edge Delta. Edge Delta has overhauled its pricing by making its Telemetry...
1d ago
EDGED
Skydio Wins $9 Million U.S. Air Force Contract to Deploy Autonomous Docked Drones in Middle East

Skydio Wins $9 Million U.S. Air Force Contract to Deploy Autonomous Docked Drones in Middle East

New updates have been reported about Skydio. Skydio has secured an order of more than $9 million from...
1d ago
SKYDI
Nerd Apply Opens Core Data Platform Free to Counselors, Expanding Admissions Intelligence Network

Nerd Apply Opens Core Data Platform Free to Counselors, Expanding Admissions Intelligence Network

New updates have been reported about Nerd Apply. Nerd Apply is restructuring its go-to-market model by making its...
1d ago
NERDA
Hello Soju Strikes Landmark LAFC Deal to Accelerate U.S. Expansion and RTD Growth

Hello Soju Strikes Landmark LAFC Deal to Accelerate U.S. Expansion and RTD Growth

New updates have been reported about Hello Soju. Hello Soju has signed a landmark partnership with Major League...
1d ago
HELLO